we conducted auantitative momhometric measurements on oulIndomethacin, because of its prostaglandin inhibition, may cause constriction of the ductus arteriosus and affect the pulmonary circulation. To study this possibility, we gave indomethacin daily by gavage to two groups of pregnant rats from the 17th day of pregnancy through delivery (group 1.2 mg/kg/day; group 2,4 mg/ kg/day). Group 3, untreated control pregnant rats, received saline. The pups were killed 30 min after birth and heart-lung preparations were perfused with glutaraldehyde. Appropriate blocks were processed for quantitative morphometry of the pulmonary arteries and arterioles. For analysis, the vessels were grouped by external diameter, i.e., <30, 30 to 50, and 50 to 100 pm. Groups 1 and 2
of lung par&chymal components were determined by point counting. Indomethacin-treated animals had an increased saccular wall miss, decreased airspace mass, and a decreased capillary to saccular wall ratio (P < 0.05). These results show that the fetal pulmonary circulation's response to indomethacin comprises the appearance of medial hypertrophy and newly muscularized arterioles. When these changes occur in lungs with immature, thick saccular walls, there is a decreased surface for oxygen exchange and an increased pulmonary vascular resistance resulting in a persistent fetal circulation.
Speculation
Indomethacin, during pregnancy, may cause constriction of the ductus arteriosus and induce a persistent fetal circulation in the newborn. Inasmuch as salicylat~s also may be causative agents of persistent fetal circulation, their use by pregnant women should be carefully examined.
Indornethacin, a potent prostaglandin synthetase inhibitor used to prevent premature labor, has been shown in studies from our laboratory and others (10-12, 18,24,36,42) to constrict the patent ductus aheriosus of the fetus when administered to the mother. Such partial constriction of the patent ductus arteriosus in utero would divert blood into the lungs and away from the descending aorta which would be disadvantageous for fetal oxygenation. To maintain fetal oxygenation, a compensatory increase in pulmonary vascular resistance may occur which would keep pulmonary blood flow low and increase blood flow through the ductus arteriosus into the descending aorta to maintain adequate levels of placental blood flow. Such changes could induce morphologic changes in the vessel walls of the pulmonary circulation resembling those observed in persistent fetal circulation (PFC). Thus, to evaluate the possible role of indomethacin in inducing the PFC syndrome, monary vessels'obtained from hewborn animals whose mothers received indomethacin during pregnancy and compared these measurements to control newborn animals whose mothers received a placebo.
MATERIALS AND METHODS
Eight Sprague-Dawley female rats who were littermates (Hill Top Lab Animals) were impregnated on the same day. These animals were randomly assigned to one of three groups. Group 1 ( N = 3) received indomethacin at a dose of 2 mg/kg/day. Group 2 (N = 3) received indomethacin at a dose of 4 mg/kg/daj. ~r o u p 3 f N = 2) received eauivalent volumes of sterile water and served as'contrdls. The indohethacin solution was mixed fresh daily, and the various solutions given by ball-tipped gavage needle. The dams were dosed from day 17 of pregnancy until delivery, a period selected to correspond to the last 2 to 3 months of a human pregnancy.
AUTOPSY STUDIES
Newborn rats were killed within 30 min of birth by intraperitoneal injection of phenobarbital. The chest was opened, and the rib cage was removed. The ductus arteriosus was examined for patency using a dissecting microscope. In all animals, it appeared closed. In the indomethacin-treated animals, the ductus arteriosus was smaller than in control animals. A needle was tied in the trachea, and a needle was inserted into the right ventricle. Both were simultaneously given injections of 3% glutaraldehyde in cacodylate buffer until the lungs were fully distended, and there was blanching of the pulmonary vascular bed. The removed heartlung preparation was then fixed in the glutaraldehyde for 2 hr and then put into the cacodylate buffer, pH 7.2 (27). One pm-thick slices were prepared from appropriate blocks and stained with toluidine blue for microscopic examination. At least 10 sections per animal were prepared for quantitative morphometric measurements. The histologic slides were coded so that their origins were unknown to the grading observer.
MORPHOMETRIC MEASUREMENTS AND ANALYSIS
Pulmonary arteries were distinguished from veins as follows: (I) for a given diameter, veins have less muscle and more connective tissue than arteries; (2) in a muscular vein, there is no internal elastic lamina; (3) the larger veins run at the edge of an acinus; (4) in a given length, small veins will have more tributaries than the arteries; and (5) after the simultaneous injection technique, only the veins should still contain red blood cells (27) .
Using a camera lucida, the slides were projected at XI00 magnification, and the pulmonary arteries were traced. Tracings were made from at least 10 sections from each rat pup. Quantita-tive morphometric measurements were made using an electronic pen (Graf Pen-3) connected to a HP 9825 programmable calculator. The measurements obtained were: external diameter, medial thickness, intimal area, and the number of intimal cell nuclei. The external diameter, taken to the shortest diameter, and the other measurements (27, (29) (30) (31) are shown in Figure I . Only vessels which could be clearly distinguished as arteries or arterioles with an internal elastic lamina were analyzed. Vessels were grouped for analysis by external diameter into three groups: t 3 0 pm, 30 to 50 pm, and 50 to 100 pm. From 2 to 5 vessels were analyzed in each size group from each section. At least 30 vessels in each size group were analyzed from each rat pup. The relative masses of lung parenchymal components were determined by point counting of sections of peripheral lung tissue (28, 29-31, 34, 35 ). An eyepiece containing a metric grid was used to examine each histologic slide. A Hewlett-Packard 9825A desk top calculator was programmed to accumulate the counted points and calculate the percentage of area of each parenchymal component. We used the formula presented by Elias et al. (7) for volume ratios using the point-counting method. This formula, modified by Page and McCallister (34) and Mobley and Page (28) is:
Vi/V,hue = Pi/P tissue where VI = the volume of the component, Vthu. = the volume of the total tissue sample, P i = the number of points lying on the component, and Pthue = the number of points lying on the total tissue sample. At least five fields were counted from each histologic slide and about 50 fields were measured from each rat pup. AU results were compared to control values using Student's unpaired t test (44). 
RESULTS

No. of pups
The number of live births and stillborns occurring in the three groups are presented in Table 1 . The indomethacin-treated groups controls. The stillborn animals did not appear macerated or less mature than their littennates, nor did they give any indication that they had died long before birth.
PULMONARY VASCULAR CHANGES
The quantitative morphometric measurements of pulmonary arteries and arterioles of the newborn animals are presented in Figures 2 and 3 . Arteries from groups I and 2 showed an increased medial smooth muscle mass in 30 to 50 and 50 to 100 pm vessels.
The 30 to 50 pm vessels had increased medial thickness and medial area whereas the 50 to 100 pm vessels showed an increased medial area. Muscularized arterioles, t30 pm in diameter, were present in both groups 1 and 2, but were not found in group 3 control.
PULMONARY PARENCHYMAL CHANGES
The relative mass of lung parenchymal components, i.e., capillaries, air spaces, and saccular walls, are shown in Figure 4 . There was no difference (P c 0.5) between groups I and 2, so the indomethacin-treated animals were grouped together and compared to the controls. The relative mass of capillaries was similar in treated and control animals, but the indomethacin-treated animals showed an increased saccular wall mass (P c 0.001) and a decreased air space mass (P < 0.05). There was also a significant (P < 0.001) decrease of the capillary mass/saccular wall mass ratio in the treated animals (Fig. 5) . These findings are similar to those observed in immature lungs and result in decreased surface for oxygen exchange.
DISCUSSION
Prostaglandin synthetase inhibitors given directly to the mammalian fetus (10-12, 18) or indirectly via maternal dosage (24, 36, 41, 42) are known to cause constriction or closure of the fetal ductus arteriosus. An increasing sensitivity to these agents has been shown as the fetus nears term (42). Constriction of the ductus arteriosus causes fetal pulmonary hypertension (1 1, 18) which leads to the development of increased amounts of pulmonary vascular smooth muscle (22) .
Premature closure of the ductus arteriosus as a cause of neonatal cardiopulmonary distress was first noted in 1969 (1) and over the next decade has become recognized more and more. Estimates of frequency indicate it may be as high as ' / l a births (37) and a cause of neonatal death in 4~ births (19).
In the early 1970's. a syndrome called PFC was recognized and defined as the clinical presentation of cyanosis and other signs of respiratory distress secondary to cardiovascular problems but without organic heart disease, and the presence of right to left shunting across the ductus arteriosus and/or foramen ovale secondary to a persistent increased pulmonary vascular resistance (13). The PFC syndrome was first reported by Arcilla et al. (I) in the infant of a mother treated for 2 wk with salicylates. Four main etiologies, i.e., hyperviscosity, hypoglycemia, a typical respiratory distress syndrome, and idiopathic were proposed. During 1976 During -1977 , multiple articles about PFC were published, in which infants with recognized and treatable causes such as hyperviscosity or hypoglycemia were excluded, and effort was focused on the idiopathic category (21). A clearer picture emerged of PFC in these infants; some thought it to be a complication of transient tachypnea of the newborn (2). and initially, it seemed to be relatively nonserious and transient syndrome. More experience showed however that some of these infants presented with evidence of myocardial dysfunction as well as congestive heart failure (33, 39), transient tricuspid insufficiency (3.41). and/or echocardiographic changes indicative of biventricular dysfunction or right ventricular dysfunction alone (38). In these groups, mortality ranged from 20 to 36% (33, 37, 45) . Although transient tricuspid insufficiency may be directly related to birth or prenatal asphyxia and consequent papillary muscle ischemia or infarction, Levin et al. (21) have angiographically demonstrated its occurrence in patients with PFC. The phenomena of increased arterial muscle mass was noted by Haworth and Reid (16) and the idea of premature ductal closure as a cause was first raised. The changes in arterial muscle mass was pursued, primarily by Levin et al. (20, 23) . in PFC associated with aortic coarctation or diaphragmatic hernia (32). Reports of PFC in newborns of mothers receiving indomethacin prompted further investigation with the resulting recent paper by Levin et al. on the pulmonary, hemodynamic, and myocardial changes in fetal lambs whose ductus was constricted by maternal dosage with indomethacin (25). Our results in this paper show that both medial hypertrophy and newly muscularized arterioles appear. When these changes occur in lungs with immature, thick saccular walls (4) as were seen in the indomethacin-treated animals, there is a decreased surface for oxygen exchange and the potential for excessively increased pulmonary vascular resistance resulting in the persistent fetal circulation syndrome. These changes in the pulmonary vascular bed mimic those described by Meyrick and Reid (27) in continued hypoxia induced by exposure to low barometric pressure. This suggests that hypoxia may be a component of PFC inducing the pulmonary vascular changes.
The results from our work and others as noted above puts the use of indomethacin in pregnant women under severe question. Work in animals has shown that doses ranging from 2.5 to 5.0 mg/kg/day cause significant ductal constriction (36,42) and with a dose as low as 3.2 mg/kg/day for 4.5 to 5.0 days complete premature closure in 1 to 3% (36). Cardiopulmonary distress in infants of mothers receiving indomethacin (in doses of 100 to 200 mg/day) has been reported by several groups (6, 26, 40) . In one such group, PFC developed in 17% of the newborns (40), and in another group, PFC occurred in 50% with a WO mortality among the infants with PFC (6).
Equally alarming is the possible causative role of PFC by salicylates. Significant ductal constriction by sodium salicylate was first reported in 1975 by Sharpe, with doses of 50 to 100 mg/ kg (42). Acetylsalicylic acid (ASA) was given to fetal lambs in a study by Heymann and Rudolph (17) . They showed ductal constriction and changes in the combined ventricular output with an increase to the lungs, adrenals, and heart and a decrease to the brain, extremities, and remaining viscera (17). Apparently, this line of inquiry has not been pursued, and of particular concern
